These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 23712734)

  • 1. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
    Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S; Bueno de Mesquita M; Mimouni FB
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of long-term use of proton pump inhibitors in children.
    De Bruyne P; Ito S
    Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
    J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.
    Kierkus J; Oracz G; Korczowski B; Szymanska E; Wiernicka A; Woynarowski M
    Drug Saf; 2014 May; 37(5):309-16. PubMed ID: 24706290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.
    Ward RM; Kearns GL
    Paediatr Drugs; 2013 Apr; 15(2):119-31. PubMed ID: 23512128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review.
    Miyazaki H; Igarashi A; Takeuchi T; Teng L; Uda A; Deguchi H; Higuchi K; Tango T
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1316-1328. PubMed ID: 30883868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C; Tvete IF; Hatlebakk JG
    Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.
    Miwa H; Igarashi A; Teng L; Uda A; Deguchi H; Tango T
    J Gastroenterol; 2019 Aug; 54(8):718-729. PubMed ID: 30919071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V; Di Mario F; Scarpignato C
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European pediatricians' approach to children with GER symptoms: survey of the implementation of 2009 NASPGHAN-ESPGHAN guidelines.
    Quitadamo P; Papadopoulou A; Wenzl T; Urbonas V; Kneepkens CM; Roman E; Orel R; Pavkov DJ; Dias JA; Vandenplas Y; Kostovski A; Miele E; Villani A; Staiano A
    J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):505-9. PubMed ID: 24663035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor use in infants: FDA reviewer experience.
    Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
    Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J
    Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.
    Romano C; Chiaro A; Comito D; Loddo I; Ferrau V
    Curr Clin Pharmacol; 2011 Feb; 6(1):41-7. PubMed ID: 21235462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.